Stock 1786 SCIVISION BIOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials SciVision Biotech Inc.

Equities

1786

TW0001786002

Medical Equipment, Supplies & Distribution

End-of-day quote Taiwan S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
108 TWD -1.37% Intraday chart for SciVision Biotech Inc. +3.85% +39.18%
Apr. 10 SciVision Biotech Inc.?s Products, Flexotron Solo (2.2%) and Flexotron Magnum (3%) Obtain Medical Device Licenses CI
Apr. 09 Scivision Biotech Inc.'s CREATEFILL Obtains Medical Device License of Class III Medical Devices CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 3,478 4,172 3,764 3,283 3,587 5,254
Enterprise Value (EV) 1 3,531 4,055 3,672 3,220 3,382 4,857
P/E ratio 39.5 x 35.5 x 30.2 x 32.8 x 28.2 x 32.2 x
Yield 2.44% 1.89% 1.56% 2.86% 3.69% 3.22%
Capitalization / Revenue 10.6 x 9.53 x 8.06 x 6.49 x 6.44 x 7.37 x
EV / Revenue 10.7 x 9.26 x 7.86 x 6.37 x 6.07 x 6.81 x
EV / EBITDA 34.9 x 27.8 x 22.9 x 18.6 x 17.3 x 18.6 x
EV / FCF -131 x -59.1 x -254 x 344 x 34.1 x 25.7 x
FCF Yield -0.77% -1.69% -0.39% 0.29% 2.93% 3.9%
Price to Book 3.23 x 3.07 x 2.68 x 2.26 x 2.37 x 3.23 x
Nbr of stocks (in thousands) 60,494 66,190 66,190 66,190 66,190 67,710
Reference price 2 57.49 63.02 56.87 49.60 54.20 77.60
Announcement Date 3/28/19 3/25/20 3/25/21 3/24/22 3/22/23 3/7/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 329.6 437.9 466.9 505.5 557.3 713
EBITDA 1 101.1 146 160.2 173.1 195.4 261.4
EBIT 1 80.66 134.2 146.6 121.9 134.6 199.6
Operating Margin 24.47% 30.65% 31.41% 24.12% 24.15% 28%
Earnings before Tax (EBT) 1 93.1 134.3 152.5 116.1 173.6 210
Net income 1 86.87 120.7 128 101.7 141.7 177.9
Net margin 26.36% 27.57% 27.42% 20.12% 25.43% 24.95%
EPS 2 1.457 1.777 1.880 1.510 1.922 2.408
Free Cash Flow 1 -27.04 -68.66 -14.43 9.364 99.15 189.2
FCF margin -8.2% -15.68% -3.09% 1.85% 17.79% 26.54%
FCF Conversion (EBITDA) - - - 5.41% 50.75% 72.38%
FCF Conversion (Net income) - - - 9.21% 69.96% 106.36%
Dividend per Share 2 1.404 1.194 0.8847 1.418 2.000 2.500
Announcement Date 3/28/19 3/25/20 3/25/21 3/24/22 3/22/23 3/7/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 52.8 - - - - -
Net Cash position 1 - 117 92.2 62.7 206 397
Leverage (Debt/EBITDA) 0.522 x - - - - -
Free Cash Flow 1 -27 -68.7 -14.4 9.36 99.1 189
ROE (net income / shareholders' equity) 8.72% 9.9% 9.26% 7.13% 9.57% 11.3%
ROA (Net income/ Total Assets) 3.09% 4.71% 4.88% 3.67% 3.86% 5.86%
Assets 1 2,808 2,560 2,621 2,771 3,672 3,036
Book Value Per Share 2 17.80 20.60 21.20 21.90 22.80 24.00
Cash Flow per Share 2 6.100 5.000 6.000 9.950 8.870 7.550
Capex 1 94.2 201 66.8 25.8 15 14.7
Capex / Sales 28.58% 45.87% 14.32% 5.1% 2.68% 2.07%
Announcement Date 3/28/19 3/25/20 3/25/21 3/24/22 3/22/23 3/7/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Devices & Implants

1st Jan change Capi.
SCIVISION BIOTECH INC. Stock SciVision Biotech Inc.
+39.18% 224M
STRYKER CORPORATION Stock Stryker Corporation
+12.07% 128B
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-9.04% 10.65B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
+0.91% 8.82B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
+16.72% 7.19B
GLAUKOS CORPORATION Stock Glaukos Corporation
+25.15% 4.99B
AXONICS, INC. Stock Axonics, Inc.
+7.17% 3.4B
ENOVIS CORPORATION Stock Enovis Corporation
-1.36% 3.03B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-8.73% 2.14B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-10.15% 2B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. 1786 Stock
  4. Financials SciVision Biotech Inc.